Clinical Trials and Preclinical Infrastructure Asset Map - Life Sciences
Clinical Trials and Preclinical Infrastructure Asset Map - Life Sciences
Clinical Trials and Preclinical Infrastructure Asset Map - Life Sciences
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
306<br />
BRITISH COLUMBIA<br />
APPENDIX 12. PRECLINICAL STUDIES SERVICE ORGANIZATIONS<br />
Company/ URL Contact Information Therapeutic Expertise <strong>and</strong> Types of Services Structure Number<br />
<strong>and</strong> Type of<br />
Staffing<br />
BCCA Investigational Drug<br />
Program (IDP)<br />
www.bccrc.ca/at/focus_investigationaldrugprogram.html<br />
B.C. Cancer Agency Research<br />
Centre<br />
675 West 10th Avenue<br />
Vancouver, B.C.<br />
V5Z 1L3<br />
Tel : 604-675-8000<br />
Head: Marcel Bally<br />
Tel :604-675-8020<br />
mbally@bccrc.ca<br />
<strong>Clinical</strong> <strong>Trials</strong> Support Services<br />
Contact: Dawn Waterhouse<br />
Tel : 604-675-8022<br />
dwater@bccrc.ca<br />
Provides facilities for the pharmaceutical formulation, manufacturing <strong>and</strong><br />
pre-clinical testing of new parenteral drugs for Phase I <strong>and</strong> II clinical trials.<br />
Complies with Good Manufacturing Practice <strong>and</strong> Good Laboratory Practice.<br />
It has a m<strong>and</strong>ate to develop promising new therapeutic agents for new<br />
anticancer agents introduction into clinical trials.<br />
IDP operates a pharmaceutical GMP clean room facility for manufacturing<br />
<strong>and</strong> packaging of parenteral drug products for Phase I <strong>and</strong> Phase II clinical<br />
trials, primarily in the cancer sector; <strong>and</strong> also non-cancer therapeutic applications.<br />
Non-<strong>Clinical</strong> Safety Studies/Toxicology<br />
Conducted by IDP through the B.C. <strong>Preclinical</strong> Research Consortium; compliant<br />
with OECD Principles of Good Laboratory Practices<br />
GMP Formulation <strong>and</strong> Manufacturing Services<br />
Services range from core batching <strong>and</strong> filling activities to comprehensive<br />
development, validation, production <strong>and</strong> documentation projects. Core<br />
services provided by Investigational Drug Program for all final drug production<br />
runs:<br />
• Process development <strong>and</strong> validation<br />
• Material control <strong>and</strong> inventory documentation<br />
•Vendor qualification<br />
• Master formula/batch record design <strong>and</strong> implementation<br />
•Batch production to 10 litres or 1500 vials/day<br />
•Facility cleaning <strong>and</strong> environmental monitoring<br />
•Sterilisation / depyrogenization of equipment <strong>and</strong> packaging materials<br />
•Basic batching processes <strong>and</strong> formulation<br />
•Product sterilization through aseptic filling of final drug product<br />
Vial sizes from 1 ml to 50 ml<br />
• Comprehensive Quality Management System<br />
• Product inspection <strong>and</strong> labeling<br />
IDP is a<br />
business<br />
unit within<br />
the BCCA,<br />
<strong>and</strong> is<br />
part of the<br />
Advanced<br />
Therapeutics<br />
Department.<br />
16 employees<br />
based in<br />
Vancouver<br />
Animal technicians:<br />
5<br />
Study Directors:<br />
2<br />
Tissue Culture<br />
Manager: 1<br />
Quality<br />
Management/<br />
Documentation:<br />
3<br />
GMP Manufacturing:<br />
2.5<br />
FTE plus 1 FTE<br />
co-op student<br />
Analytical: 2<br />
<strong>Clinical</strong> trials<br />
support: 2<br />
plus 1 co-op<br />
Types of<br />
Clients<br />
Predominantly<br />
services<br />
B.C. science<br />
community;.<br />
with some<br />
clients in<br />
Canada,<br />
North<br />
America<br />
<strong>and</strong><br />
Europe.<br />
Clients<br />
include<br />
SMEs,<br />
Hospitals,<br />
Institutions,<br />
University<br />
Med<br />
schools,<br />
<strong>and</strong> small<br />
operations<br />
requiring<br />
CT operations,<br />
manufacturing,<br />
<strong>and</strong><br />
services<br />
Regulatory<br />
Qualifications<br />
Animal<br />
facility <strong>and</strong><br />
testing areas<br />
compliant<br />
with:<br />
OECD GLP<br />
practices<br />
cGMP Clean<br />
Room Facility<br />
complies<br />
with:<br />
US FDA 21<br />
CFR Parts<br />
210 <strong>and</strong> 211<br />
Health<br />
Canada<br />
HPFBI GMP<br />
guidelines.